Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1441239

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1441239

Global Intravenous Infusion Pump Market Size, Share, Growth Analysis, By By Product(Volumetric Infusion Pumps, Insulin Infusion Pumps), By By Disease Indication(Chemotherapy, Diabetes) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Intravenous Infusion Pump Market size was valued at USD 5.3 billion in 2022 and is poised to grow from USD 5.74 billion in 2023 to USD 10.86 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2024-2031).

The global market for intravenous (IV) infusion pumps has witnessed substantial growth, attributed to the increasing prevalence of chronic illnesses, a burgeoning elderly population, and advancements in medical technology. These pumps play a pivotal role in delivering fluids, medications, and nutrients directly into patients' veins with precision and control. Key drivers of this market expansion include the growing demand for home healthcare services, especially for continuous infusion therapies, and the imperative for precise drug administration in clinical environments. Additionally, efforts to mitigate medication errors, enhance patient safety, and improve treatment outcomes contribute to market momentum. The future trajectory of the IV infusion pump market hinges on the development of intuitive, interconnected devices prioritizing patient safety and treatment efficacy, as well as the ongoing integration of data-driven technologies and patient-centered designs to meet the evolving requirements of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Infusion Pump Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Infusion Pump Market Segmental Analysis

The Global Intravenous Infusion Pump Market is segmented on the basis of Product, Disease Indication, and region. By Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps, Others. By Disease Indication, the market is segmented into Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Intravenous Infusion Pump Market

The rising occurrence of chronic conditions like cancer, diabetes, and cardiovascular ailments, combined with a worldwide aging demographic, fuels the necessity for intravenous (IV) infusion pumps. These tools play a vital role in precisely delivering medications, fluids, and nutrients to patients undergoing extended treatments, thereby enhancing disease control and fostering better patient results.

Restraints in the Global Intravenous Infusion Pump Market

Advanced intravenous infusion pumps, though highly effective, may pose significant financial challenges due to their expensive acquisition and maintenance costs, including calibration, upkeep, and training expenses. Such financial burdens can significantly strain healthcare budgets, posing a formidable barrier for healthcare facilities, especially in resource-limited settings or areas with constrained financial resources dedicated to healthcare.

Market Trends of the Global Intravenous Infusion Pump Market

The surge in Smart and Connected Infusion Pumps, which amalgamate technology and connectivity, marks a notable advancement in intravenous infusion systems. These intelligent pumps provide functionalities like dose calculation aid, seamless wireless integration with electronic health records (EHR) systems, and live monitoring of infusion metrics. This trend not only elevates patient safety but also enhances healthcare provider workflow efficiency, enabling remote monitoring and adjustments. The momentum towards digital healthcare solutions has spurred the uptake of smart infusion pumps, promising to mitigate medication errors and optimize the administration process.

Product Code: SQMIG35A2492

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Intravenous Infusion Pump Market by By Product

  • Market Overview
  • Volumetric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient Controlled Analgesia (PCA)
  • Implantable Infusion Pumps
  • and Others

Global Intravenous Infusion Pump Market by By Disease Indication

  • Market Overview
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • and Others

Global Intravenous Infusion Pump Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moog Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zyno Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hospira, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Halyard Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Micrel Medical Devices SA (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caesarea Medical Electronics Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sino Medical-Device Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tricumed Medizintechnik GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coopdech (Thailand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Q Core Medical Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!